BOK Financial’s Pfizer PFE Stock Holding History

BOK Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.62M	Sell	93,196 -26,853	-22%	-$715K	0.04%	287
2025 Q4	$2.99M	Sell	120,049 -11,310	-9%	-$285K	0.05%	267
2025 Q3	$3.35M	Buy	131,359 +14,869	+13%	+$367K	0.05%	260
2025 Q2	$2.82M	Sell	116,490 -2,161	-2%	-$50.4K	0.05%	286
2025 Q1	$3.01M	Sell	118,651 -6,010	-5%	-$157K	0.05%	268
2024 Q4	$3.33M	Sell	124,661 -18,412	-13%	-$499K	0.06%	247
2024 Q3	$4.05M	Sell	143,073 -10,784	-7%	-$315K	0.07%	225
2024 Q2	$4.3M	Sell	153,857 -48,114	-24%	-$1.32M	0.08%	218
2024 Q1	$5.6M	Sell	201,971 -85,332	-30%	-$2.37M	0.1%	193
2023 Q4	$8.27M	Sell	287,303 -35,632	-11%	-$1.08M	0.16%	138
2023 Q3	$9.87M	Sell	322,935 -65,560	-17%	-$2.32M	0.22%	101
2023 Q2	$14.2M	Sell	388,495 -30,103	-7%	-$1.17M	0.29%	84
2023 Q1	$17.1M	Sell	418,598 -206,256	-33%	-$8.91M	0.36%	62
2022 Q4	$32M	Sell	624,854 -7,719	-1%	-$370K	0.59%	39
2022 Q3	$27.7M	Buy	632,573 +15,323	+2%	+$745K	0.56%	38
2022 Q2	$32.4M	Buy	617,250 +6,565	+1%	+$335K	0.62%	36
2022 Q1	$31.6M	Buy	610,685 +85,662	+16%	+$4.44M	0.52%	42
2021 Q4	$31M	Buy	525,023 +20,284	+4%	+$1M	0.48%	48
2021 Q3	$21.7M	Buy	+504,739	New	+$22.4M	0.37%	63
2021 Q1	$19.5M	Sell	539,244 -223,372	-29%	-$7.93M	0.36%	64
2020 Q4	$28.1M	Sell	762,616 -122,872	-14%	-$4.51M	0.54%	41
2020 Q3	$30.8M	Buy	885,488 +77,418	+10%	+$2.71M	0.68%	26
2020 Q2	$25.1M	Buy	808,070 +72,868	+10%	+$2.48M	0.59%	36
2020 Q1	$22.8M	Buy	735,202 +6,415	+0.9%	+$219K	0.66%	28
2019 Q4	$27.1M	Buy	728,787 +69,174	+10%	+$2.46M	0.61%	27
2019 Q3	$22.5M	Sell	659,613 -108,448	-14%	-$3.94M	0.54%	38
2019 Q2	$31.6M	Sell	768,061 -63,626	-8%	-$2.53M	0.76%	21
2019 Q1	$33.5M	Sell	831,687 -16,206	-2%	-$649K	0.8%	18
2018 Q4	$35.1M	Buy	847,893 +216,152	+34%	+$8.97M	1%	11
2018 Q3	$26.4M	Buy	631,741 +46,810	+8%	+$1.8M	0.66%	26
2018 Q2	$20.1M	Sell	584,931 -26,913	-4%	-$920K	0.54%	37
2018 Q1	$20.6M	Buy	611,844 +17,960	+3%	+$617K	0.59%	33
2017 Q4	$20.4M	Buy	593,884 +2,754	+0.5%	+$93.9K	0.56%	37
2017 Q3	$20M	Buy	591,130 +7,273	+1%	+$234K	0.58%	34
2017 Q2	$18.6M	Sell	583,857 -15,570	-3%	-$491K	0.59%	36
2017 Q1	$19.5M	Buy	599,427 +14,320	+2%	+$451K	0.61%	33
2016 Q4	$18M	Buy	585,107 +3,047	+0.5%	+$93K	0.59%	30
2016 Q3	$18.7M	Buy	582,060 +118,588	+26%	+$3.97M	0.62%	27
2016 Q2	$15.5M	Buy	463,472 +14,236	+3%	+$454K	0.55%	35
2016 Q1	$12.6M	Buy	449,236 +3,632	+0.8%	+$104K	0.46%	51
2015 Q4	$13.6M	Buy	445,604 +14,376	+3%	+$452K	0.49%	44
2015 Q3	$12.9M	Sell	431,228 -3,711	-0.9%	-$119K	0.48%	46
2015 Q2	$13.8M	Buy	434,939 +41,230	+10%	+$1.34M	0.47%	46
2015 Q1	$13M	Sell	393,709 -247,293	-39%	-$7.86M	0.44%	49
2014 Q4	$18.9M	Buy	641,002 +280,557	+78%	+$8.04M	0.65%	32
2014 Q3	$10.1M	Sell	360,445 -118,688	-25%	-$3.33M	0.34%	61
2014 Q2	$13.5M	Sell	479,133 -33,102	-6%	-$944K	0.43%	44
2014 Q1	$15.6M	Buy	512,235 +59,226	+13%	+$1.77M	0.52%	32
2013 Q4	$13.2M	Sell	453,009 -8,583	-2%	-$250K	0.44%	41
2013 Q3	$12.6M	Buy	461,592 +6,554	+1%	+$178K	0.46%	44
2013 Q2	$12.1M	Buy	+455,038	New	+$12.6M	0.46%	49

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BOK Financial's PFE Position: Q1 2026 in Review

BOK Financial reduced its Pfizer (PFE) stake by 22% in Q1 2026, selling an estimated $715K and leaving 93,196 shares worth $2.62M. The position accounts for 0.04% of the portfolio, ranked #287.

BOK Financial first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $35.1M in Q4 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

BOK Financial held 93,196 shares of Pfizer worth $2.62M as of Q1 2026.
BOK Financial sold 26,853 Pfizer shares in Q1 2026, an estimated $715K.
Pfizer made up 0.04% of BOK Financial's portfolio in Q1 2026, its #287 holding.
BOK Financial first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
BOK Financial's Pfizer position peaked at $35.1M in Q4 2018.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.